Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving orthopedic patient communication using text messaging

Official title: Patient Reported Outcomes Measures Pilot Grant for Orthopedic Patients

Run by Boston Medical Center · NCT04441567 · Data updated 2026-11-12

This study is testing if using text messages to check in with orthopedic patients can help them stay engaged and track their recovery better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorBoston Medical Center
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMay 10, 2021
Main results expectedJune 2029
Study endsJune 2029
Registry record updatedOctober 7, 2026
Trial IDNCT04441567 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with specific orthopedic conditions who have sustained injuries within the last three weeks and have access to a mobile phone.

Probably not a fit

Patients without a cellular phone or those who are unable to read or communicate effectively may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance communication with orthopedic patients by utilizing the Memora Health text messaging platform for administering Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires. Participants will complete these questionnaires via SMS or a secure weblink on their mobile phones, allowing for better tracking of health status. The study will evaluate the effectiveness of these methods in improving patient engagement and will develop recovery curves based on the collected data over a year. In the second phase, the study will compare individual recovery against established benchmarks to optimize clinic visit schedules.

Why it matters

Potential benefit: If successful, this approach could lead to more personalized and efficient care for orthopedic patients, improving their recovery experience.

How similar studies have gone: Other studies have shown promise in using mobile technology for patient engagement, indicating that this approach could be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects that are classified by the Current Procedural Terminology/International Classification of Diseases (CPT/ICD)-10 Diagnosis Codes, having sustained the injury within 3 weeks of enrollment for non-operative treatment or will undergo surgery during the enrollment period:
* Ankle Fracture
* Distal Radius Fracture
* Tibial Plateau Open reduction internal fixation (ORIF)
* Spine Operative

  * Anterior cervical discectomy with fusion (ACDF)
  * Cervical Laminectomy
  * Lumbar Fusion
  * Lumbar Decompression
* Spine Non-operative

  * Lumbar Stenosis
  * Lumbar Degenerative Disc Disease
* Rotator Cuff Repair
* Anterior cruciate ligament (ACL) Reconstruction
* Have personal use of cellular phone with access to the internet
* Speak either English or English as a primary language:

Exclusion Criteria:

* Limited and non-readers
* Vulnerable populations - incarcerated patients
* Patients with no cell phone to use for scoring

Where it's running

  • Boston Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.